You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: December 2023 to October 2025

AbstractFullPdf
Dec 2023873882672
Jan 2024263265155
Feb 202417617999
Mar 2024215217165
Apr 2024186187142
May 202419319393
Jun 202412012094
Jul 202412312495
Aug 202411511675
Sep 2024899362
Oct 202410810991
Nov 202410510675
Dec 202414815165
Jan 202513413484
Feb 202522522577
Mar 2025868674
Apr 202514114185
May 2025127127112
Jun 2025939373
Jul 2025330
Oct 2025112
Total352435522390